메뉴 건너뛰기




Volumn 13, Issue 6, 2011, Pages 1015-1025

Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone

Author keywords

Atovaquone; Bioadhesion; Cyclodextrin; Nanoparticles; Oral delivery

Indexed keywords

ATOVAQUONE; BIOADHESION; BIOADHESIVES; DESOLVATION; DRUG CARRIER; DRUG LOADING; IN-VIVO; LIPOPHILIC DRUGS; LOADING CAPACITIES; METHYLCELLULOSE; NANOPARTICLE FORMULATION; ORAL DELIVERY; PHARMACOKINETIC STUDIES; PHYSICOCHEMICAL PROPERTY; RELATIVE BIOAVAILABILITY; SUSPENSION CONTROL;

EID: 84855417564     PISSN: 13872176     EISSN: 15728781     Source Type: Journal    
DOI: 10.1007/s10544-011-9571-1     Document Type: Article
Times cited : (21)

References (39)
  • 12
    • 84855680034 scopus 로고    scopus 로고
    • US Patent number 6649659
    • A.R. Dearn, US Patent number 6649659 (2000)
    • (2000)
    • Dearn, A.R.1
  • 16
    • 84855673815 scopus 로고    scopus 로고
    • GlaxoSmithKline. Wellvone 750 mg/5 mL oral suspension [Online]. Available at:, Accessed on 10 January
    • GlaxoSmithKline. Wellvone 750 mg/5 mL oral suspension [Online]. Available at: http://www.medicines.org.uk/EMC/medicine/777/SPC/ Wellvone%20750mg%205ml%20oral%20suspension/#FORM. Accessed on 10 January 2011
    • (2011)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.